Bend OR 间质性肺病临床试验
7项针对 间质性肺病的研究正在 Bend及周边约 30 英里内的站点招募参与者。打开研究详情可查看入选标准及联系研究团队的方式。
官方研究文本（英文）
Efficacy and Safety Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
招募中3 期
- USA003, Bend
A Phase 3 Trial of Inhaled Mosliciguat in PH-ILD (PHrontier)
招募中3 期
- Clinical Research Site, Bend
A Phase 3 Study to Evaluate the Safety and Efficacy L606 in Participants With PH-ILD
招募中3 期
- Summit Health, Bend
DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
招募中观察性研究
- Summit Health, Bend
An Open-Label Extension Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
招募中3 期
- USA003, Bend
A Study of ROC-101 in Patients With Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension Associated With Interstitial Lung Disease (ILD-PH) (ROCSTAR STUDY)
招募中2 期
- Bend Memorial Clinic, Bend
An Open-Label ProSpective MultiCENTer Study to Evaluate Safety and Tolerability of Dry Powder Inhaled Treprostinil in PH
招募中观察性研究
- Summit Health, Bend
其他城市的 间质性肺病试验
- New York City, NY19 项研究
- Philadelphia, PA17 项研究
- Los Angeles, CA15 项研究
- Kansas City, KS14 项研究
- Chicago, IL13 项研究
- Charleston, SC13 项研究
- Houston, TX13 项研究
- Durham, NC13 项研究
- Ann Arbor, MI11 项研究
- Aurora, CO11 项研究
- Birmingham, AL10 项研究
- Rochester, MN10 项研究
Bend的其他研究
数据来自 ClinicalTrials.gov，检索日期：2026年9月30日。每项研究自行设定入选标准，由研究团队决定谁能参与。